NYU Langone Health: Combination Immunotherapy Shows High Activity Against Recurrent Hodgkin Lymphoma

Press/Media

Period3 Dec 2018

Media coverage

1

Media coverage

  • TitleNYU Langone Health: Combination Immunotherapy Shows High Activity Against Recurrent Hodgkin Lymphoma
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date3/12/18
    PersonsJonathan Cohen
View all 1
View less